Cencora Inc (NYSE: COR) started the day on Wednesday, with a price increase of 2.75% at $354.0, before settling in for the price of $344.53 at the close. Taking a more long-term approach, COR posted a 52-week range of $223.92-$350.46.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 13.29%. Meanwhile, its Annual Earning per share during the time was 13.29%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 9.26%. This publicly-traded company’s shares outstanding now amounts to $193.86 million, simultaneously with a float of $185.75 million. The organization now has a market capitalization sitting at $68.63 billion. At the time of writing, stock’s 50-day Moving Average stood at $311.46, while the 200-day Moving Average is $286.92.
Cencora Inc (COR) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Medical Distribution Industry. Cencora Inc’s current insider ownership accounts for 4.19%, in contrast to 94.85% institutional ownership. According to the most recent insider trade that took place on Oct 20 ’25, this organization’s President & CEO sold 5,097 shares at the rate of 326.80, making the entire transaction reach 1,665,700 in total value, affecting insider ownership by 37,940.
Cencora Inc (COR) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 4.89 per share during the current fiscal year.
Cencora Inc’s EPS increase for this current 12-month fiscal period is 9.26% and is forecasted to reach 19.31 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 10.04% through the next 5 years, which can be compared against the 13.29% growth it accomplished over the previous five years trading on the market.
Cencora Inc (NYSE: COR) Trading Performance Indicators
Let’s observe the current performance indicators for Cencora Inc (COR). It’s Quick Ratio in the last reported quarter now stands at 0.53. Alongside those numbers, its PE Ratio stands at $36.42, and its Beta score is 0.64. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 0.22. Similarly, its price to free cash flow for trailing twelve months is now 60.12.
In the same vein, COR’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 9.72, a figure that is expected to reach 4.03 in the next quarter, and analysts are predicting that it will be 19.31 at the market close of one year from today.
Technical Analysis of Cencora Inc (COR)
If we take a close look at the recent performances of Cencora Inc (NYSE: COR), its last 5-days Average volume was 1.99 million that shows progress from its year to date volume of 1.54 million. During the previous 9 days, stock’s Stochastic %D was recorded 71.10% While, its Average True Range was 82.61.
Raw Stochastic average of Cencora Inc (COR) in the period of the previous 100 days is set at 91.61%, which indicates a major rise in contrast to 82.43% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 7.50 that was higher than 6.41 volatility it exhibited in the past 100-days period.






